Chapter Plus+ By Backslim Capsules pose a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested a product labelled Chapter Plus+ By Backslim Capsules and found that:
- the capsules contain the undeclared substance sibutramine.
Consumers are advised that sibutramine is a prescription-only medicine (which was the active ingredient in Reductil). It was withdrawn in October 2010 after a study showed an increased risk of major cardiac events.
The supply of Chapter Plus+ By Backslim Capsules containing undisclosed sibutramine is illegal.
Chapter Plus+ By Backslim Capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
TGA investigations have shown that a number of people in Australia may have bought the product online.